Judith Wallenstein leads the BCG Henderson Institute in Europe. She is a core member of the German Health Care practice, focused on serving clients in the pharmaceutical industry.

Judith became a BCG Fellow in 2015; through her analysis, she is examining the implications of the sharing economy and the future of work.

Judith’s pharma work has centered on strategy, marketing and sales, and portfolio management. She is passionate about the ever-increasing challenges of great product launches in pharma and serves as the firm’s global topic lead for launch excellence in the pharmaceutical sector. She is also the topic lead, with Charles-André Brouwers, for growth in pharma.

Most of her client work is focused on diabetes, immunology, and oncology, as well as on rare disease.

Judith joined BCG's Munich office in 2000. She spent 18 months in the Madrid office and 12 months in the New York office as the Strategy Institute's first ambassador in 2005. Beyond her client work, Judith is part of the team managing BCG's partnership with TED and is involved in Women@BCG, a companywide career development, mentorship, and networking program.

Judith's initial career plan was to become a diplomat before an internship with BCG put her on a different track. She holds Master's degrees in history and German and French literature from Ludwig-Maximilians-Universität in Munich.


  • Marketing in biopharma
  • Launch excellence
  • Brand strategy
  • Transformation
  • Marketing capabilities
  • Return on marketing investment
  • Return on capital investment


  • Master’s degree, history and German and French literature, Ludwig-Maximilians-Universität
Deep Expertise, Broad Experience